US WorldMeds completes $55 million acquisition of Adaptimmune cell therapy assets Aug 4, 2025 04:00PM
US WorldMeds Completes Acquisition of Adaptimmune's Cell-Therapy Portfolio; Ensures Continued Patient Access to Tecelra and Advances Development of lete-cel Aug 4, 2025 04:00PM
Adaptimmune to sell cell therapy assets to US WorldMeds for $55 million Jul 28, 2025 07:33AM
Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds Jul 28, 2025 07:30AM
Adaptimmune Reports Q1 Financial Results and Provides Business Update May 13, 2025 07:30AM


Mar 20, 2025 07:00AM Adaptimmune Provides Q4 and Full Year 2024 Business Update
May 15, 2024 07:02AM Adaptimmune Therapeutics (ADAP) Secures up to $125 Million Debt Financing with Hercules Capital
May 15, 2024 07:00AM Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital
Mar 6, 2023 06:01AM Adaptimmune (ADAP) and TCR2 (TCRR) to Merge
Mar 6, 2023 06:00AM Adaptimmune and TCR² Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors
Mar 6, 2023 06:00AM Adaptimmune and TCR² Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors
Mar 6, 2023 06:00AM Adaptimmune and TCR2 Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors
Jun 4, 2020 10:45AM Adaptimmune Therapeutics plc Announces Closing of Public Offering of American Depositary Shares
Jun 2, 2020 05:52AM Adaptimmune Therapeutics (ADAP) Prices 20.5M ADS Offering at $11/ADS
Jun 1, 2020 09:38PM Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares
Jun 1, 2020 06:12AM Adaptimmune Therapeutics (ADAP) Announces Proposed 12.5M ADS Offering
Jun 1, 2020 06:00AM Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
Feb 7, 2020 04:05PM Adaptimmune Therapeutics plc Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional American Depositary Shares
Jan 24, 2020 04:30PM Adaptimmune Therapeutics plc Announces Closing of Public Offering of American Depositary Shares
Jan 22, 2020 08:49AM Adaptimmune Therapeutics (ADAP) Prices 21 Million Offering at $4/ADS
Jan 22, 2020 08:48AM Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares
Jan 21, 2020 04:09PM Adaptimmune Therapeutics (ADAP) Plans Offering of ADSs
Jan 21, 2020 04:08PM Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
Mar 27, 2017 11:26AM Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
Mar 22, 2017 09:51AM Adaptimmune Therapeutics (ADAP) Prices 14.3M Offering at $4.20/ADS
Mar 22, 2017 09:51AM Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares
Mar 21, 2017 04:55PM Adaptimmune Therapeutics (ADAP) Plans Offering of American Depositary Shares
Mar 21, 2017 04:55PM Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
Mar 2, 2017 08:00AM Adaptimmune to Present at the Cowen and Company 37th Annual Health Care Conference
Mar 2, 2016 10:30AM Adaptimmune to Present at Cowen and Company’s 36th Annual Health Care Conference
Jun 1, 2015 06:21AM Cowen Starts Adaptimmune Therapeutics plc (ADAP) at Outperform
May 11, 2015 11:49AM Adaptimmune Announces Closing of Initial Public Offering
May 6, 2015 10:45AM Adaptimmune Therapeutics (ADAP) IPO Opens Up 13%
May 6, 2015 10:05AM Adaptimmune Therapeutics (ADAP) Prices 11.25M IPO at $17/ADS
May 6, 2015 07:00AM Adaptimmune Announces Pricing of Initial Public Offering
Apr 7, 2015 09:56AM Adaptimmune Therapeutics (ADAP) Files $150M IPO